NCT02038023View on ClinicalTrials.gov

Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women

PHASE2CompletedINTERVENTIONAL

Enrollment

74

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions

Pregnancy

Interventions

DRUG

Intravaneous iron(low molecular weight iron dextran)

1000 mg of Iron dextran administered over one hour

Trial Locations (1)

21237

Auerbach Hematology Oncology Assoc, Baltimore

Sponsors

Collaborators (1)

Pharmacosmos A/S

All Listed Sponsors

collaborator

Pharmacosmos A/S

INDUSTRY

lead

Auerbach Hematology Oncology Associates P C

OTHER